Puma Biotechnology Stock Price on January 2, 2025
| PBYI Stock | USD 3.74 0.19 5.35% |
If you're considering investing in Puma Stock, it is important to understand the factors that can impact its price. As of today, the current price of Puma Biotechnology stands at 3.74, as last reported on the 8th of January, with the highest price reaching 4.06 and the lowest price hitting 3.73 during the day. Puma Biotechnology appears to be very risky, given 3 months investment horizon. Puma Biotechnology maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12% return per unit of risk over the last 3 months. By analyzing Puma Biotechnology's technical indicators, you can evaluate if the expected return of 0.66% is justified by implied risk. Please evaluate Puma Biotechnology's Semi Deviation of 4.46, coefficient of variation of 810.82, and Risk Adjusted Performance of 0.1078 to confirm if our risk estimates are consistent with your expectations.
Puma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Puma |
Sharpe Ratio = 0.1233
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PBYI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.36 actual daily | 47 53% of assets are more volatile |
Expected Return
| 0.66 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Puma Biotechnology is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Puma Biotechnology by adding it to a well-diversified portfolio.
Related Headline
Ultragenyx Headline on 2nd of January 2025
Gene Therapy Market to Hit Valuation of US 42.26 Billion By ... by finance.yahoo.com
Robust pipelines emphasize expanded clinical trials, global RD partnerships, and streamlined rare disease approvals. Concurrently, logistical complexities and regulatory hurdles reveal the need for specialized production strategies.New Delhi, Jan. 02, 2025 -- The global gene therapy market was valued at US 9.42 billion in 2024 and is projected to hit the market valuation of US 42.26 billion by 2033 at a CAGR of 18.15 percent during the forecast period 20252033. Today, the gene ther
Puma Biotechnology Valuation on January 2, 2025
It is possible to determine the worth of Puma Biotechnology on a given historical date. On January 2, 2025 Puma was worth 3.08 at the beginning of the trading date compared to the closed value of 3.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Puma Biotechnology stock. Still, in general, we apply an absolute valuation method to find Puma Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Puma Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Puma Biotechnology's related companies.
| Open | High | Low | Close | Volume | |
| 3.15 | 3.17 | 2.99 | 3.05 | 284,161 | |
01/02/2025 | 3.08 | 3.37 | 3.08 | 3.12 | 682,387 |
| 3.11 | 3.19 | 2.92 | 2.95 | 844,715 |
| Backtest Puma Biotechnology | | | Puma Biotechnology History | | | Puma Biotechnology Valuation | Previous | Next |
Puma Biotechnology Trading Date Momentum on January 2, 2025
| On January 03 2025 Puma Biotechnology was traded for 2.95 at the closing time. The top price for the day was 3.19 and the lowest listed price was 2.92 . The trading volume for the day was 844.7 K. The trading history from January 3, 2025 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 5.45% . The trading delta at closing time against the current closing price is 22.76% . |
Puma Biotechnology Fundamentals Correlations and Trends
By evaluating Puma Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Puma Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Puma financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Puma Biotechnology Stock history
Puma Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Puma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Puma Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Puma Biotechnology stock prices may prove useful in developing a viable investing in Puma Biotechnology
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company was founded in 2010 and is headquartered in Los Angeles, California. Puma Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 196 people.
Puma Biotechnology Stock Technical Analysis
Puma Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Puma Biotechnology Period Price Range
Low | January 8, 2025
| High |
0.00 | 0.00 |
Puma Biotechnology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Puma Biotechnology January 8, 2025 Market Strength
Market strength indicators help investors to evaluate how Puma Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Puma Biotechnology shares will generate the highest return on investment. By undertsting and applying Puma Biotechnology stock market strength indicators, traders can identify Puma Biotechnology entry and exit signals to maximize returns
Puma Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Puma Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Puma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Puma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1078 | |||
| Jensen Alpha | 0.6521 | |||
| Total Risk Alpha | 0.6546 | |||
| Sortino Ratio | 0.1218 | |||
| Treynor Ratio | 0.3032 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |